Not a bad read, but really not his best work. N
Post# of 148326
(Total Views: 697)
Posted On: 06/26/2020 12:13:56 AM
Re: crazyjogger925 #39240
Not a bad read, but really not his best work.
Not comprehensive by any means (I'm really glad Ohm20 provided some potential indication specificity in the comments section), somewhat discontiguous in terms of subject matter, and some material inaccuracies, which are surprising.
For example, we know that not all of the TnBC patients have CTCs at zero.
And, although the professor at Montefiore who wants to do a very quick Alzheimer's study HAS 400 available patients -- that doesn't mean this quick study will consist of 400 subjects.
Specific Link: https://youtu.be/uOC0yvBe1pA?t=1246
There are other issues, but there's no reason to nit pick.
I think he's very good writer, and I like his thought process -- but this seems a bit uncharacteristically slapped together.
Not comprehensive by any means (I'm really glad Ohm20 provided some potential indication specificity in the comments section), somewhat discontiguous in terms of subject matter, and some material inaccuracies, which are surprising.
For example, we know that not all of the TnBC patients have CTCs at zero.
And, although the professor at Montefiore who wants to do a very quick Alzheimer's study HAS 400 available patients -- that doesn't mean this quick study will consist of 400 subjects.
Specific Link: https://youtu.be/uOC0yvBe1pA?t=1246
There are other issues, but there's no reason to nit pick.
I think he's very good writer, and I like his thought process -- but this seems a bit uncharacteristically slapped together.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼